Fountain Life Review: Membership Cost and What to Confirm

Our assessment

Fountain Life offers an extensive preventive-health program built around advanced imaging and physician interpretation. Its public shop currently lists CORE Diagnostics at $10,500 and APEX Membership at $23,500. Those are published product prices checked on October 15, 2026. The storefront product data marks both available; that does not establish appointment availability, a personalized quote or every included service.¹²

Our grade remains B, 8 out of 14 under our commercial and service rubric. The appeal is coordinated testing and access to a medical team. The unresolved questions are the exact package, ongoing-care charges and the financial responsibility for investigating a finding. A long test menu also does not establish that screening healthy people with the whole package improves survival.

This is a review of public offers and published research. We have not purchased a membership, undergone Fountain Life testing or reviewed a signed member contract. For the broader choice, see longevity clinics versus lab memberships and Fountain Life versus Human Longevity.

What Fountain Life offers

CORE's dedicated page describes diagnostic testing, a physician review, a personalized plan and an annual Zori AI membership. APEX's page describes broader diagnostics, optional therapeutics and round-the-clock access to a team including a physician, nurse, health coach, nutritionist and care coordinator. These are the company's advertised services; this review does not independently verify individual members' delivery or outcomes.³⁴

Fountain Life identifies William Kapp, MD, as co-founder and CEO, and Dawn Mussallem, DO, as chief medical officer. Its founding partners also include Peter Diamandis, Tony Robbins and Robert Hariri. Their involvement establishes the named leadership, not independent validation of every screening or treatment claim.⁵

The homepage lists Dallas, Orlando, Naples, New York and Houston, with Miami marked as forthcoming. The New York address is in White Plains; the Dallas address is in The Colony. Los Angeles has a separate announcement for fall 2027. We therefore do not describe six centers as currently operating. Confirm the appointment address and available services before booking travel.⁶⁷⁸

Membership prices and the cancer-test listing

The current shop listings are the clearest public dollar figures we found. The marketing describes annual memberships, but a shop price alone does not settle renewal pricing, eligibility, location-specific charges or the scope of your agreement.¹²⁴

APEX Family needs its own quote. Its dedicated page describes an annual experience for members' children aged 18–30. It should not be read as a household version of APEX for adults of any age. We did not find a dollar price on that page.⁹

The shop separately lists the multi-cancer early detection blood test at $949. A separate listing does not establish whether a particular quoted package includes the test. Obtain a written answer for CORE, APEX or APEX Family rather than assume that the brand's early-detection message guarantees inclusion.¹¹ Our Galleri review explains the test's limitations.

Why a written service list matters

The public tier descriptions provide a useful overview, but they are not a signed entitlement schedule. Ask for an itemized list showing which imaging, blood tests, genetic tests and clinician visits your price covers, how often each can be repeated, and which require an extra fee or a medical indication. CORE's page describes a physician results review; APEX's page advertises a broader ongoing team. Confirm those distinctions in the offer you receive.³⁴

For APEX Family, ask specifically about the cancer blood test's inclusion, frequency and medical eligibility. A broad diagnostic menu does not settle those details for a young adult.⁹

Deposits, cancellation and follow-up costs

There is a published deposit condition. The CORE product page says a deposit becomes nonrefundable within 30 days of the scheduled appointment, with credit toward a rescheduled appointment. It does not explain every circumstance outside that window, and we would not automatically apply a CORE product condition to APEX or a different purchase.¹

A separate CORE listing labeled final payment shows $7,000. That is a balance-payment product, not evidence that the complete program costs $7,000. Nor does subtracting it from another listing reliably establish the deposit required for a new member today.¹²

The website's general terms page is dated April 11, 2020 and refers to Augment Your Immunity services. We could not establish it as the current CORE or APEX membership agreement. On the membership, tier, shop and terms pages reviewed, we did not find a complete explanation of automatic renewal, renewal price, membership cancellation and refunds. That is a scoped observation about those pages, not a claim that no agreement exists.¹³

Fountain Life does advertise care coordination and follow-up support.⁴⁷ Support is different from paying for every subsequent test or treatment. We could not establish from the reviewed offer pages whether outside specialist visits, repeat imaging, biopsy, hospital care or treatment are covered. We also cannot conclude that all follow-up is excluded. Before paying, request a written estimate that addresses both the membership and the next steps after an abnormal result.

What the screening evidence supports

MRI can find disease; that is not the same as proving a survival benefit

An incidental finding is not automatically a false positive, and an early diagnosis does not by itself show that a screening program prevents death. Our Fountain Life versus Human Longevity comparison examines the MRI research and explains why study populations and follow-up methods matter.

The American College of Radiology's published position does not recommend total-body screening for people without symptoms, risk factors or a relevant family history, citing insufficient evidence and potential unnecessary investigations and expense. This position concerns general screening; it does not replace a clinician's assessment of a specific symptom or inherited risk.¹⁴

A cancer blood test can start a lengthy workup

The National Cancer Institute says definitive clinical trials have not established that multi-cancer screening reduces overall cancer mortality. A negative result should not replace recommended breast, cervical, colorectal or eligible lung screening. A positive screening result requires additional diagnostic testing; discuss personal risk and the plan for that workup before adding the test.¹⁵¹⁶

Marketing outcomes and restorative treatments

Fountain Life's homepage reports fourfold higher cancer detection, 46% reversal of accelerated brain aging and 12% significant plaque reversal. The displayed statistics do not supply the study population, comparison method and follow-up needed to evaluate those claims. We cannot infer a screening mortality benefit or causal treatment effect from those figures alone.⁶

The APEX page also promotes optional treatments with the possibility of reversing cellular aging.⁴ That marketing claim should not be read as proof that the offered package extends healthy life. Our plasma exchange evidence guide reviews the emerging human studies, their limitations and the distinction between changes in biomarkers and demonstrated health benefits.

Fountain Life's membership page itself flags its restorative biologics as not FDA approved.¹⁰ Ask which treatment is being proposed, its clinical indication, its risks and its regulatory status. See biological age tests, NAD+ for longevity and what's proven versus hyped for related evidence.

Who may find it useful

Fountain Life may appeal to someone who values one coordinated assessment, can afford the quoted package and potential downstream costs, and wants a physician to interpret a large set of results. The practical value depends on whether those results lead to appropriate, evidence-based care for that person's risks.

If your interest is specifically a standalone MRI appointment, our Prenuvo review compares that narrower service with a broader clinic program.

Fountain Life is harder to justify if the main goal is inexpensive preventive care, a guaranteed all-inclusive price, reassurance without the possibility of indeterminate findings, or a proven way to extend life. Maintain ordinary primary care and recommended screening alongside any concierge program.

Before a deposit, obtain three things: an itemized service list for your tier and center; the current agreement covering cancellation, refunds and renewal; and a written plan for who arranges and pays for investigating abnormal findings. Include the cancer blood test and ongoing clinician access in that discussion.

Our grade and verdict

Our existing 8/14, B score comprises longevity services 4/4, clinical oversight 2/2, human support 2/2, price transparency 0/4 and pharmacy disclosure 0/2. It measures published service and commercial criteria, not a probability of benefit or a clinical endorsement. The advertised testing breadth, physician review and care team support the service points; we have not independently measured the quality of delivered care.

The price factor specifically rewards an ungated, all-in price available to a month-to-month buyer without commitment. Fountain Life advertises annual programs; the reviewed listings do not establish a no-commitment month-to-month offer. That is why the price factor receives 0/4 under the published rubric, even though public reference prices exist. Pharmacy points remain unawarded because this review did not establish dispensing-pharmacy disclosure for a particular prescription pathway; this does not imply an unsafe pharmacy.

Fountain Life merits consideration as a premium diagnostic and care-coordination service. Its menu and marketing outcomes should not be mistaken for proof that the complete program extends healthy life. A clear written offer and a measured screening discussion are the deciding steps. Compare our provider rankings, how we grade and the Next Health review.